Vox Sang. 1995;68(4):236-40.

ABO blood group genotype and plasma von Willebrand factor in normal individuals.

Shima M, Fujimura Y, Nishiyama T, Tsujiuchi T, Narita N, Matsui T, Titani K, Katayama M, Yamamoto F, Yoshioka A.

Source

Department of Pediatrics, Nara Medical University, Kashihara.

Abstract

von Willebrand factor (vWF) is a multimeric plasma protein with ABO (H) blood group sugar chains. We investigated a total of 330 plasmas from normal individuals having various ABO genotypes, with special reference to vWF antigen and its platelet glycoprotein-Ib-related biological activities, termed ristocetin cofactor (RCof) and botrocetin cofactor (BCof). RCof reflects the biological activity of higher vWF multimers, while BCof reflects that of vWF of multimers of all sizes. Plasmas from normal individuals carrying one O gene (genotypes AO and BO) had slightly, but proportionally lower levels of vWF antigen, RCof, and BCof than those carrying no O gene (genotypes AA, AB, and BB). Normal plasmas from individuals carrying two O genes (genotype OO) showed much lower values for these parameters than the other plasmas, as previously reported. However, multimeric analysis of plasma vWF antigen revealed no differences among the different genotypes.

PMID:: 7660643; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Medical

VWF Gene - Genetics Home Reference

Supplemental Content

Related citations

Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. [Arterioscler Thromb Vasc Biol. 2002]
Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels.
O'Donnell J, Boulton FE, Manning RA, Laffan MA. Arterioscler Thromb Vasc Biol. 2002 Feb 1; 22(2):335-41.
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications. [Semin Thromb Hemost. 2002]
Response of von Willebrand factor parameters to desmopressin in patients with type 1 and type 2 congenital von Willebrand disease: diagnostic and therapeutic implications.
Michiels JJ, van de Velde A, van Vliet HH, van der Planken M, Schroyens W, Berneman Z. Semin Thromb Hemost. 2002 Apr; 28(2):111-32.
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. [Arterioscler Thromb Vasc Biol. 2000]
Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time.
Souto JC, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, Mateo J, Madoz P, Stone W, Blangero J, et al. Arterioscler Thromb Vasc Biol. 2000 Aug; 20(8):2024-8.
Review Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD. [Clin Appl Thromb Hemost. 2006]
Review Characterization of recessive severe type 1 and 3 von Willebrand Disease (VWD), asymptomatic heterozygous carriers versus bloodgroup O-related von Willebrand factor deficiency, and dominant type 1 VWD.
Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van de Velde A, van Vliet H. Clin Appl Thromb Hemost. 2006 Jul; 12(3):277-95.
Review Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1. [Acta Haematol. 2009]
Review Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ, Berneman Z, Gadisseur A, van der Planken M, Schroyens W, van Vliet HH. Acta Haematol. 2009; 121(2-3):85-97. Epub 2009 Jun 8.

See reviews... See all...

Cited by 5 PubMed Central articles

The clinical value of von Willebrand factor in colorectal carcinomas. [Am J Transl Res. 2011]
The clinical value of von Willebrand factor in colorectal carcinomas.
Schellerer VS, Mueller-Bergh L, Merkel S, Zimmermann R, Weiss D, Schlabrakowski A, Naschberger E, Stürzl M, Hohenberger W, Croner RS. Am J Transl Res. 2011; 3(5):445-53. Epub 2011 Sep 23.
ABO genotype and risk of thrombotic events and hemorrhagic stroke. [J Thromb Haemost. 2009]
ABO genotype and risk of thrombotic events and hemorrhagic stroke.
Wiggins KL, Smith NL, Glazer NL, Rosendaal FR, Heckbert SR, Psaty BM, Rice KM, Lumley T. J Thromb Haemost. 2009 Feb; 7(2):263-9. Epub 2008 Nov 25.
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma. [Blood Transfus. 2008]
Recommendations from the Tuscan Transfusion System on the appropriate use of solvent/detergent-inactivated fresh-frozen plasma.
Liumbruno GM, Sodini ML, Grazzini G, Tuscan Transfusion System. Blood Transfus. 2008 Jan; 6(1):25-36.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

ABO blood group genotype and plasma von Willebrand factor in normal individuals.
ABO blood group genotype and plasma von Willebrand factor in normal individuals.
Vox Sang. 1995 ;68(4):236-40.

PubMed
Low-dose naltrexone for disease prevention and quality of life.
Low-dose naltrexone for disease prevention and quality of life.
Med Hypotheses. 2009 Mar ;72(3):333-7. Epub 2008 Nov 28 .

PubMed
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.
Malignant mesothelioma after radiation treatment for Hodgkin lymphoma.
Blood. 2009 Apr 16 ;113(16):3679-81. Epub 2009 Feb 20 .

PubMed
Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonar...
Transgenic mice enriched in omega-3 fatty acids are more susceptible to pulmonary tuberculosis: impaired resistance to tuberculosis in fat-1 mice.
J Infect Dis. 2010 Feb 1 ;201(3):399-408.

PubMed
Matrix metalloproteinases: they're not just for matrix anymore!
Matrix metalloproteinases: they're not just for matrix anymore!
Curr Opin Cell Biol. 2001 Oct ;13(5):534-40.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: